Heart Failure: Implications for Quality Improvement and Hands-on Training

Pharmacy Times, November 2016 Cough, Cold, & Flu, Volume 82, Issue 11

This Continuing Education activity is supported by an educational grant from Novartis Pharmaceuticals Corporation..

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation..

Heart Failure: Implications for Quality Improvement and Hands-on Training

Faculty

Sneha Baxi Srivastava, PharmD, BCACP, CDE

Clinical Associate ProfessorChicago State University College of PharmacyChicago, IllinoisClinical PharmacistACCESS Community Health NetworkChicago, Illinois

Educational Objectives

After completing this continuing education program, the participant will be able to:

  • Apply guideline-directed medical therapies to patients with heart failure
  • Identify the role of newer therapies for heart failure
  • Explore the role of the pharmacist in management of heart failure in the inpatient, transitional, and outpatient settings
  • Demonstrate patient counseling skills to provide optimal patient-centered care for patients with heart failure

Target audience: Pharmacists, including community and health-systems pharmacists

Type of activity: Application

Release date: October 31, 2016

Expiration date: November 30, 2017

Estimated time to complete activity: 3.0 hours

Fee: Free

Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 3.0 contact hours (0.30 CEUs) under the ACPE universal activity number 0290-0000-16-141-H01-P. The activity is available for CE credit through November 30, 2017.